June 03, 2024 06:13 GMT
Glaxo (GSK: A2 / A): Zantac ruling
HEALTHCARE
A judge in Delaware permitted jury trials for up to 72,000 plaintiffs in Zantac cases.
GSK are seeking an immediate appeal against the decision.
{https://www.ft.com/content/b5d60754-9635-4909-9481...}
{https://www.gsk.com/en-gb/media/press-releases/sta...}
Keep reading...Show less
24 words